Mesenchymal stem/stromal cell–based therapies for COVID-19: First iteration of a living systematic review and meta-analysis: MSCs and COVID-19

BACKGROUND: Mesenchymal stem/stromal cells (MSCs) and their secreted products are a promising therapy for COVID-19 given their immunomodulatory and tissue repair capabilities. Many small studies were launched at the onset of the pandemic, and repeated meta-analysis is critical to obtain timely and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirkham, Aidan M., Monaghan, Madeline, Bailey, Adrian J.M., Shorr, Risa, Lalu, Manoj M., Fergusson, Dean A., Allan, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2022
Materias:
Full-Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802614/
https://www.ncbi.nlm.nih.gov/pubmed/35219584
http://dx.doi.org/10.1016/j.jcyt.2021.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802614/
https://www.ncbi.nlm.nih.gov/pubmed/35219584
http://dx.doi.org/10.1016/j.jcyt.2021.12.001

Ejemplares similares